Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GlaxoSmithKline submits application for SAD indication for Paxil tablet in Japan

Sep. 21, 2007

Alexza to begin first of two phase III trials of AZ-004

Sep. 21, 2007

Discovery of agents for neurological disorders reported in recent patent literature

Sep. 21, 2007

Natural products for the treatment of sleep disorders

Sep. 21, 2007

mGlu2/3 receptor activation with LY-2140023 improves schizophrenia symptoms

Sep. 20, 2007

Sosei completes phase II proof-of-principle trial of AD-337 for FMS

Sep. 20, 2007

Recent patents describe novel agents for psychiatric disorders

Sep. 20, 2007

Snapshots of clinical results in sleep research

Sep. 19, 2007

Patient enrollment completed for Sciele Pharma's pivotal phase III trial of glycopyrrolate

Sep. 19, 2007

Cannasat Therapeutics' pain therapy delivered with IntelGenx technology in phase I trial

Sep. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026